Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP9 ME-TRAP and MVA ME-TRAP malaria vaccine trial in Kenyan children
ISRCTN88335123Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Feb 2005
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in malaria comparing FP9 ME-TRAP followed by MVA ME-TRAP with Rabies vaccine control (2 arms). Primary endpoints: Safety, Immunogenicity and 3 more. Started Feb 2005; status: completed.
02
Drugs
FP9 ME-TRAPMVA ME-TRAPRabies vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN88335123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88335123.